Clinical Trial Update: A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial). [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a combinatorial therapy using albumin and enoxaparin in patients with decompensated cirrhosis at high risk of poor outcomes; c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Cirrhosis
• Liver Cirrhosis
• On Chronic Liver Failure

Drugs mentioned

• Albumin
• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: European Foundation for Study of Chronic Liver Failure | Conditions: Liver Cirrhosis, Decompensated Cirrhosis of Liver | Phase 2 | Status: RECRUITING